-
- 抗原 See all LRRC17 抗体
- LRRC17 (Leucine Rich Repeat Containing 17 (LRRC17))
-
抗原表位
- Middle Region
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This LRRC17 antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 特异性
- LRRC17 antibody was raised against the middle region of LRRC17
- 纯化方法
- Affinity purified
- 免疫原
- LRRC17 antibody was raised using the middle region of LRRC17 corresponding to a region with amino acids YVFPIQTLDCKRKELKKVPNNIPPDIVKLDLSYNKINQLRPKEFEDVHEL
- Top Product
- Discover our top product LRRC17 Primary Antibody
-
anti-Leucine Rich Repeat Containing 17 (LRRC17) (AA 245-294) antibody
LRRC17 适用: 人, 马, 犬, 猴, Pig WB 宿主: 兔 Polyclonal unconjugated
anti-Leucine Rich Repeat Containing 17 (LRRC17) (AA 1-441) antibodyLRRC17 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Leucine Rich Repeat Containing 17 (LRRC17) (Middle Region) antibodyLRRC17 适用: 人, 马, Cow, 犬, 豚鼠, 小鼠, 兔, 大鼠, 斑马鱼 WB 宿主: 兔 Polyclonal unconjugated
anti-Leucine Rich Repeat Containing 17 (LRRC17) antibodyLRRC17 适用: 人 WB, ELISA 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
WB: 0.5 µg/mL
Optimal conditions should be determined by the investigator. - 说明
-
LRRC17 Blocking Peptide, catalog no. 33R-10275, is also available for use as a blocking control in assays to test for specificity of this LRRC17 antibody
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of LRRC17 antibody in PBS
- 浓度
- Lot specific
- 缓冲液
- PBS
- 注意事项
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - 储存条件
- 4 °C/-20 °C
- 储存方法
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- 抗原
- LRRC17 (Leucine Rich Repeat Containing 17 (LRRC17))
- 别名
- LRRC17 (LRRC17 产品)
- 别名
- P37NB antibody, 37kDa antibody, 4833425M04Rik antibody, 6130400C22Rik antibody, P37nb antibody, leucine rich repeat containing 17 antibody, Lrrc17 antibody, LRRC17 antibody
- 背景
- LRRC17 contains 6 LRR (leucine-rich) repeats. The exact function of LRRC17 remains unknown.
- 分子量
- 52 kDa (MW of target protein)
-
You are here:
